GlassScriptPhysician profile
Kathryn Brown
NPI 1790336113
$2,984.14
in general payments reported to CMS, 2019-2025
27 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $157 · 2022: $527 · 2023: $574 · 2024: $1,578 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,300.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $546.30 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $340.84 | 2021-2025 | Fasenra, Breztri, Farxiga |
| Teva Pharmaceuticals USA, INC. | $261.72 | 2024 | Uzedy, Austedo Xr |
| Boehringer Ingelheim Pharmaceuticals, INC. | $248.81 | 2022-2025 | Jardiance |
| Amgen INC. | $201.75 | 2024-2025 | Krystexxa, Otezla, Repatha |
| Lilly USA, LLC | $165.24 | 2022-2024 | Jardiance, Zepbound, Mounjaro |
| Ethicon US, LLC | $123.56 | 2022 | |
| Pfizer INC. | $105.72 | 2024-2025 | |
| Edwards Lifesciences Corporation | $102.86 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $99.86 | 2022 | |
| Alexion Pharmaceuticals, INC. | $78.57 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $78.34 | 2024 | Caplyta |
| Astellas Pharma US INC | $78.12 | 2023-2024 | Veozah |
| Mannkind Corporation | $77.91 | 2023 | Afrezza |
| Corcept Therapeutics | $76.96 | 2023 | Korlym |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $68.58 | 2023-2025 | Gardasil 9, Vaxelis, Capvaxive |
| Inari Medical, INC. | $68.49 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Exact Sciences Corporation | $47.21 | 2024 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $46.63 | 2024 | Gvoke Hypopen |
| Boston Scientific Corporation | $37.95 | 2024 | Watchman Access System |
| Tactile Systems Technology INC | $24.30 | 2024 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $21.67 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $20.35 | 2024 | Spravato |
| Glaxosmithkline, LLC. | $17.13 | 2024 | Arexvy, Shingrix, Bexsero |
| Novo Nordisk INC | $16.54 | 2024 | Ozempic, Rybelsus |
| Almatica Pharma LLC | $14.59 | 2024 | Teriparatide |
| Bayer Healthcare Pharmaceuticals INC. | $14.14 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.